APEC trustees Prof Andrew Shennan and Dianne Garland wrote an article with Chief Executive Marcus Green for the Charity Spotlight series in the British Medical Journal. It focuses on the charity’s support of Research into pre-eclampsia and why that is important.

Research

Action on Pre-eclampsia is willing to collaborate with any credible researchers in relevant areas. Recent efforts include defining the most important topics requiring research by The James Lind Alliance, which helps inform policymakers and funding agencies as to the most important research questions that need answering. Their wide representation means the questions are also relevant to women and their babies, and not only driven by medical concerns.

Action on Pre-eclampsia has been integrally involved in many clinical trials of interventions to improve management and outcomes of pre-eclampsia. These include tests to accurately identify those at risk, such novel blood pressure monitoring devices (Action on Pre-eclampsia, 2020c) or new blood tests (Hurrell et al, 2022). Management strategies include blood pressure management (Chappell et al, 2022; Tucker et al, 2022), and timing of birth (Beardmore-Gray et al, 2022). Research to understand why pre-eclampsia occurs also features strongly in the research APEC is involved with (Shennan and Gray, 2018).

The social impact of pre-eclampsia is equally important, and Action on Pre-eclampsia is also involved in research on bereavement support, as well as how women understand pre-eclampsia in low income settings (Robbins et al, 2021). 

Action on Pre-eclampsia understands the importance of nurturing the next generation, and has its own student scholarship, the Walker Redman award, in honour of its founders. Chris Redman has always been, and remains, a keen researcher. The scholarship gives support to any student’s research project that has the potential to add to the body of knowledge on understanding or managing pre-eclampsia.

Action on Pre-eclampsia recognises that not all research is good, nor properly conducted. The scientific board members are happy to evaluate the integrity of any relevant research and help give an independent judgement as to the research’s credibility and validity. This is critical to maintaining the dissemination of quality research and to improve outcomes for mothers and babies.

The reality is that pre-eclampsia has not gone away. Research is likely to remain a mainstay of the charity’s activities for the foreseeable future, and Action on Pre-eclampsia is here to add value to this important effort.